Enveric Biosciences Inc (ENVB) Stock Price, Quote & News

Company Profile

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules...

Industry: Biotechnology

Sector: Healthcare

Website: www.enveric.com

Address:

245 First Street, Riverview II 18 th Floor, Cambridge, United States

VelocityVector Dec. 25 at 4:34 PM

$ENVB The setup offers potential, but only if discipline accelerates faster than complexity. Reliability of results matters more than short bursts of momentum. Any disconnect between guidance and outcomes will magnify skepticism. Absent confirmation, volatility is likely to persist.

0 · Reply

victory369 Dec. 23 at 11:19 PM

$ENVB Why volume up today ? 😁 is there any news ?

0 · Reply

CantNameThatTune Dec. 23 at 11:07 PM

$BIYA While you're chasing the dream on $PCLA keep in mind the reverse on BIYA will take place Monday at 4 PM. The OS will be down to 1 mil shs and the float about 600K. If it's anything like $ENVB a couple weeks ago, it should fly up 100% -500% especially since they are booking record sales BIYA is.

2 · Reply

victory369 Dec. 23 at 8:25 PM

$ENVB What wrong with this garbage stock today ? 😁

1 · Reply

FullPorrtDipz Dec. 23 at 7:31 PM

If you like getting in them before the massive moves.. Drop @MomentumZeus a FOLLOW below. He's been calling some insane runners lately.. 🚀 Adds on $PPBT $ENVB $SIDU $CETX -

0 · Reply

Love_To_Learn Dec. 23 at 12:45 PM

$ENVB coding old beloved 5.1 and 5.25*

0 · Reply

Love_To_Learn Dec. 22 at 8:32 PM

$RETO $ENVB COME MY PET !

0 · Reply

Love_To_Learn Dec. 22 at 4:36 PM

$RETO $ENVB need u both shortly

0 · Reply

Zackpedia Dec. 17 at 11:13 PM

$ENVB You could’ve sold when I alerted and bought back at 5 if you wanted, hit Follow and subscribe to get my alerts on time and make money

0 · Reply

Hopscotch1 Dec. 17 at 5:48 PM

$ENVB Its got a good base now

0 · Reply

Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds

Dec 11, 2025, 1:43 PM EST - 13 days ago

Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds

Dec 9, 2025, 8:00 AM EST - 16 days ago

Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates

Dec 4, 2025, 8:00 AM EST - 21 days ago

Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”

Nov 26, 2025, 8:00 AM EST - 4 weeks ago

Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates

Nov 14, 2025, 4:05 PM EST - 5 weeks ago

Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results

Oct 23, 2025, 8:00 AM EDT - 2 months ago

Enveric Biosciences Announces Reverse Stock Split

Oct 16, 2025, 8:30 AM EDT - 2 months ago

Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance

Oct 15, 2025, 8:00 AM EDT - 2 months ago

Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal

Oct 14, 2025, 9:00 AM EDT - 2 months ago

Enveric Biosciences to Explore Digital Asset Treasury Opportunities

Oct 2, 2025, 8:45 AM EDT - 3 months ago

Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials

Sep 18, 2025, 4:30 PM EDT - 3 months ago

Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds

Sep 17, 2025, 9:24 AM EDT - 3 months ago

Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds

Sep 17, 2025, 8:00 AM EDT - 3 months ago

Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery

Sep 16, 2025, 8:45 AM EDT - 3 months ago

Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission

Sep 3, 2025, 8:30 AM EDT - 4 months ago

Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:30 AM EDT - 4 months ago

Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA

Aug 28, 2025, 8:30 AM EDT - 4 months ago

Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications

Aug 14, 2025, 8:00 AM EDT - 4 months ago

Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results

Jul 23, 2025, 8:03 AM EDT - 5 months ago

Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series

Jul 15, 2025, 9:03 AM EDT - 5 months ago

Enveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD)

Jun 24, 2025, 9:03 AM EDT - 6 months ago

Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003

Jun 16, 2025, 10:46 AM EDT - 6 months ago

Enveric Biosciences Announces Participation in 2025 BIO International Convention

Jun 10, 2025, 9:03 AM EDT - 7 months ago

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders

Jun 3, 2025, 9:00 AM EDT - 7 months ago

Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds

May 28, 2025, 9:03 AM EDT - 7 months ago

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003

May 20, 2025, 8:00 AM EDT - 7 months ago

Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease

May 14, 2025, 4:15 PM EDT - 8 months ago

Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results

Mar 31, 2025, 8:00 AM EDT - 9 months ago

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024

Mar 17, 2025, 1:40 PM EDT - 10 months ago

Enveric Biosciences Participating in BIO-Europe Spring®

Mar 6, 2025, 10:00 AM EST - 10 months ago

Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark

Feb 27, 2025, 9:30 AM EST - 10 months ago

Enveric Biosciences CEO Issues Letter to Shareholders

Feb 25, 2025, 1:30 PM EST - 10 months ago

Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent

Feb 4, 2025, 8:00 AM EST - 11 months ago

Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease

Feb 3, 2025, 5:00 PM EST - 11 months ago

Enveric Biosciences Announces Closing of $5 Million Public Offering

Jan 30, 2025, 8:14 PM EST - 11 months ago

Enveric Biosciences Announces Pricing of $5 Million Public Offering

Jan 30, 2025, 4:01 PM EST - 11 months ago

Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office

Jan 6, 2025, 8:30 AM EST - 1 year ago

Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025”

Dec 2, 2024, 8:00 AM EST - 1 year ago

Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds

Nov 25, 2024, 9:00 AM EST - 1 year ago

Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior

Nov 14, 2024, 4:05 PM EST - 1 year ago

Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results

Nov 12, 2024, 9:00 AM EST - 1 year ago

Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002

Nov 4, 2024, 10:36 AM EST - 1 year ago

Enveric Biosciences Announces Broad Range of Patent Issuances

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003

Sep 26, 2024, 8:30 AM EDT - 1 year ago

Enveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial Workshop

Sep 25, 2024, 8:30 AM EDT - 1 year ago

Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Enveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Aries Science & Technology and Enveric Biosciences Announce Issuance of Key US Patent Under Aries' License for Treatment of Radiation Dermatitis and Other Conditions

Aug 12, 2024, 5:30 PM EDT - 1 year ago

Enveric Biosciences Reports Second Quarter 2024 Financial and Corporate Results

Jul 25, 2024, 8:00 AM EDT - 1 year ago

Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally

VelocityVector Dec. 25 at 4:34 PM

0 · Reply

victory369 Dec. 23 at 11:19 PM

$ENVB Why volume up today ? 😁 is there any news ?

0 · Reply

CantNameThatTune Dec. 23 at 11:07 PM

2 · Reply

victory369 Dec. 23 at 8:25 PM

$ENVB What wrong with this garbage stock today ? 😁

1 · Reply

FullPorrtDipz Dec. 23 at 7:31 PM

If you like getting in them before the massive moves.. Drop @MomentumZeus a FOLLOW below. He's been calling some insane runners lately.. 🚀 Adds on $PPBT $ENVB $SIDU $CETX -

0 · Reply

Love_To_Learn Dec. 23 at 12:45 PM

$ENVB coding old beloved 5.1 and 5.25*

0 · Reply

Love_To_Learn Dec. 22 at 8:32 PM

$RETO $ENVB COME MY PET !

0 · Reply

Love_To_Learn Dec. 22 at 4:36 PM

$RETO $ENVB need u both shortly

0 · Reply

Zackpedia Dec. 17 at 11:13 PM

$ENVB You could’ve sold when I alerted and bought back at 5 if you wanted, hit Follow and subscribe to get my alerts on time and make money

0 · Reply

Hopscotch1 Dec. 17 at 5:48 PM

$ENVB Its got a good base now

0 · Reply

Tony_37 Dec. 17 at 3:19 PM

$ENVB : 38 k volume ? When 1 billion in volume 💎??

0 · Reply

Luckyjs38 Dec. 17 at 3:11 PM

$CEIN $GREE $ENVB $FLGC

0 · Reply

Luckyjs38 Dec. 17 at 2:52 PM

$CEIN Don’t sleep on these emerging companies set to disrupt their market sectors with exponential growth potential in my opinion these are especially undervalued gems. I’m accumulating and Holding Long $GREE $ENVB $FLGC $CEIN 🔮🐦‍🔥 My opinion you do you

0 · Reply

GRAEPARKER Dec. 16 at 6:12 PM

$ENVB low float biotech at support, quiet accumulation plus a single ignition day can flip this into a squeeze

2 · Reply

Luckyjs38 Dec. 16 at 5:59 PM

$ENVB

0 · Reply

Zackpedia Dec. 16 at 1:25 PM

$ENVB You could’ve sold when I alerted and bought back at 4.8 if you wanted.

0 · Reply

Hopscotch1 Dec. 15 at 5:50 PM

$ENVB all aboard

1 · Reply

Zackpedia Dec. 15 at 5:03 PM

$ENVB You could’ve sold when I alerted and bought back at 4.5 today if you wanted, resistance at 5.3 now

0 · Reply

Luckyjs38 Dec. 15 at 3:53 PM

$ENVB extremely undervalued market caps under their cash on hand 🐦‍🔥 adding the discounts holding long

0 · Reply

Etrading Dec. 14 at 3:13 AM

$ENVB

0 · Reply

JohnTrack Dec. 14 at 2:43 AM

$ENVB offering closed, now what https://www.rapidticker.com/news/envb-enveric-biosciences-announces-closing-of-8a4fed

0 · Reply

Tony_37 Dec. 13 at 9:01 PM

$ENVB : don’t report me please! But I want $50 😅

0 · Reply

Market Cap	2.79M
Revenue (ttm)	0.00
Net Income (ttm)	-9.57M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	27,800
Avg Vol	886,156
Day's Range	N/A - N/A
Shares Out	597,000.00
Stochastic %K	5%
Beta	0.22
Analysts	Strong Buy
Price Target	$10.00